Compare TWST & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | CHWY |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | 18000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 7.6B |
| IPO Year | 2018 | 2019 |
| Metric | TWST | CHWY |
|---|---|---|
| Price | $161.33 | $18.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 26 |
| Target Price | ★ $150.33 | $28.64 |
| AVG Volume (30 Days) | 2.6M | ★ 9.3M |
| Earning Date | 11-13-2026 | 09-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | $376,572,000.00 | ★ $12,601,500,000.00 |
| Revenue This Year | $21.18 | $7.32 |
| Revenue Next Year | $20.16 | $6.75 |
| P/E Ratio | ★ N/A | $44.95 |
| Revenue Growth | ★ 20.32 | 6.24 |
| 52 Week Low | $23.30 | $17.40 |
| 52 Week High | $219.71 | $39.70 |
| Indicator | TWST | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 40.96 |
| Support Level | $41.18 | $17.49 |
| Resistance Level | N/A | $24.57 |
| Average True Range (ATR) | 15.71 | 0.72 |
| MACD | -4.20 | 0.11 |
| Stochastic Oscillator | 22.29 | 38.54 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Founded in 2011, Chewy is a leading e-commerce retailer of pet food, toys, supplies, and medications in North America. The firm offers a comprehensive selection of proprietary and third-party brands, anchored by its highly sticky autoship subscription program, which drives over 83% of its sales. Beyond core retail, Chewy is expanding into high-margin revenue streams, including its retail media network (Chewy Ads), specialized veterinary healthcare software, and brick-and-mortar veterinary clinics to further integrate customers into the Chewy ecosystem.